| Ms Nicole L Mizner, CPNP | |
|
887 Congress St, Suite 310, Portland, ME 04102-3100 | |
| (207) 773-2723 | |
| (207) 773-3941 |
| Full Name | Ms Nicole L Mizner |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 887 Congress St, Portland, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003049768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | AP091039 (Maine) | Primary |
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
Smile Train, the world's leading cleft charity with over 2,200 partner surgeons operating in over 1,100 partner hospitals in over 80 countries, today announced that it has performed its 250,000th cleft repair surgery in China, since it began operations there in 1999.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
A patient's own molecular data can be used to identify, with the use of artificial intelligence methods, the best combinatorial multi-drug therapy for that patient. Network modelling plays a major role in this line of work.
It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
Smile Train, the world's leading cleft charity with over 2,200 partner surgeons operating in over 1,100 partner hospitals in over 80 countries, today announced that it has performed its 250,000th cleft repair surgery in China, since it began operations there in 1999.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
A patient's own molecular data can be used to identify, with the use of artificial intelligence methods, the best combinatorial multi-drug therapy for that patient. Network modelling plays a major role in this line of work.
It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.
› Verified 6 days ago
| Entity Name | Pediatric Cardiology Assoc Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346311925 PECOS PAC ID: 1557393220 Enrollment ID: O20050901000656 |
News Archive
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
Smile Train, the world's leading cleft charity with over 2,200 partner surgeons operating in over 1,100 partner hospitals in over 80 countries, today announced that it has performed its 250,000th cleft repair surgery in China, since it began operations there in 1999.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
A patient's own molecular data can be used to identify, with the use of artificial intelligence methods, the best combinatorial multi-drug therapy for that patient. Network modelling plays a major role in this line of work.
It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nicole L Mizner, CPNP 887 Congress St, Suite 310, Portland, ME 04102-3100 Ph: (207) 773-2723 | Ms Nicole L Mizner, CPNP 887 Congress St, Suite 310, Portland, ME 04102-3100 Ph: (207) 773-2723 |
News Archive
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
Smile Train, the world's leading cleft charity with over 2,200 partner surgeons operating in over 1,100 partner hospitals in over 80 countries, today announced that it has performed its 250,000th cleft repair surgery in China, since it began operations there in 1999.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
A patient's own molecular data can be used to identify, with the use of artificial intelligence methods, the best combinatorial multi-drug therapy for that patient. Network modelling plays a major role in this line of work.
It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.
› Verified 6 days ago
Patricia Mae Wieler, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 818 Congress St, Portland, ME 04102 Phone: 207-773-8161 | |
Olivia Polise, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Ms. Kelly Irene Daly, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 51 Sewall St Ste 1, Portland, ME 04102 Phone: 207-774-5761 Fax: 207-874-7478 | |
Katharine E Addicott, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2911 Fax: 207-662-6006 | |
Leah Victoria Mahoney, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 66 Bramhall St, Portland, ME 04102 Phone: 207-662-3157 Fax: 207-662-4257 | |
Lucy A Mack, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 161 Marginal Way, Portland, ME 04101 Phone: 207-773-7964 |